Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The current study tries to discuss the functional role of microRNA-497 (miR-497) in diabetic neuropathic pain (DNP) and the related downstream mechanism. Bioinformatics analysis was implemented for the identification of differentially expressed miRNAs and genes. DNP was simulated in rats through intraperitoneal injection of streptozotocin. The expression patterns of miR-497, USP15, NRF2, and G6PD were then determined. The binding of miR-497 and USP15 was confirmed. Using gain- and loss-of-function assays, we analyzed the critical role of miR-497-mediated USP15 in DNP through the NRF2/G6PD axis. Downregulated miR-497 and elevated USP15 were observed in the dorsal root ganglion neurons isolated from spinal cord tissues of STZ-induced DNP rats. miR-497 could alleviate DNP, which was associated with suppression of USP15, a confirmed target of miR-497. USP15 enhanced the degradation and ubiquitination of NRF2 and induced G6PD expression, leading to the progression of DNP. We highlighted the crucial role of miR-497-mediated USP15 in DNP through the NRF2/G6PD axis. 1. miR-497 is downregulated in DRG neurons from spinal cord tissues of STZ-induced DNP rats. 2. miR-497 inhibits the expression of USP15, thereby alleviating STZ-induced DNP in rats. 3. USP15 promotes ubiquitination and degradation of NRF2, reducing the expression of G6PD. 4. miR-497 alleviates STZ-induced DNP in rats by regulating the USP15/NRF2/G6PD axis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10565-022-09702-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A GABAergic neuronal thalamocortical circuit mediates the relief of diabetic neuropathic pain.
Br J Anaesth
September 2025
Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Electronic address:
Background: Diabetic neuropathic pain (DNP) is a severe and clinically common form of neuropathic pain. Ventral posterolateral nucleus (VPL) glutamatergic neurones are reportedly involved in the development of neuropathic pain. However, the roles and mechanism of VPL GABAergic neurones and neural circuits in DNP remain unclear.
View Article and Find Full Text PDFAucubin mitigates the elevation of microglial aerobic glycolysis and inflammation in diabetic neuropathic pain aldose reductase.
World J Diabetes
May 2025
Department of Anesthesiology, The First People's Hospital of Chun'an County, Hangzhou 311700, Zhejiang Province, China.
Background: Treatment of diabetic neuropathy is often limited by side effects. Aucubin, an iridoid glycoside derived from natural plants, exhibits notable anti-inflammatory and antioxidant properties.
Aim: To investigate the effects of aucubin on diabetic neuropathic pain (DNP) and glycolysis and inflammation in microglia.
Deglet Noor date derived polysaccharides lower blood glucose levels and modulate the gut microbiota in a streptozotocin-induced type-1 diabetic mouse model.
Food Funct
June 2025
Dongguan Key Laboratory of Fundamental Research and Clinical Application of Toxic Chinese Medicine, The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523121, China.
Diabetes mellitus is a chronic metabolic disorder marked by insulin deficiency and hyperglycemia. At present, pharmacotherapy involving synthetic diabetic agents is widely used, but it comes with side effects. In contrast, natural compounds like polysaccharides show promising anti-diabetic activity and are increasingly used alongside conventional therapies, especially in developing countries.
View Article and Find Full Text PDFBranched-Chain Amino Acids Deficiency Promotes Diabetic Neuropathic Pain Through Upregulating LAT1 and Inhibiting Kv1.2 Channel.
Adv Sci (Weinh)
September 2024
Institute for Developmental and Regenerative Cardiovascular Medicine, MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.
Article Synopsis
- Diabetic neuropathic pain (DNP) is a common complication of diabetes, causing significant pain and suffering in patients, particularly in the distal limbs.
- A study comparing serum metabolite levels revealed that branched-chain amino acids (BCAA) are significantly lower in DNP patients compared to those with type 2 diabetes but without neuropathy.
- Research in mouse models showed that BCAA deficiency leads to increased expression of L-type amino acid transporter 1 (LAT1), which disrupts potassium channel functioning and enhances neuronal excitability, leading to DNP symptoms; BCAA supplementation or LAT1 inhibition can alleviate these symptoms.
Electroacupuncture may alleviate diabetic neuropathic pain by inhibiting the microglia P2X4R and neuroinflammation.
Purinergic Signal
October 2023
Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
Diabetic neuropathic pain (DNP) is a common and destructive complication of diabetes mellitus. The discovery of effective therapeutic methods for DNP is vitally imperative because of the lack of effective treatments. Although 2 Hz electroacupuncture (EA) was a successful approach for relieving DNP, the mechanism underlying the effect of EA on DNP is still poorly understood.
View Article and Find Full Text PDF